Common Contracts
2 similar Collaborative Development and License Agreement contracts by Immunogen Inc
COLLABORATIVE DEVELOPMENT AND LICENSE AGREEMENTCollaborative Development and License Agreement • November 4th, 2016 • Immunogen Inc • Pharmaceutical preparations • New York
This COLLABORATIVE DEVELOPMENT AND LICENSE AGREEMENT (this “Agreement”) is entered into as of July 7, 2006 (the “Effective Date”), by and between ImmunoGen, Inc., a Massachusetts corporation with its principal place of business at 128 Sidney Street, Cambridge, Massachusetts, USA 02139 (“ImmunoGen”) and Biotest AG, a corporation organized under the laws of Germany having an address of Landsteinerstraße 5, D-63303 Dreieich, Germany (“Biotest”). Each of Biotest and ImmunoGen is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
2. ADMINISTRATION OF THE COLLABORATION 21 2.1 Joint Steering Committee 21 2.2 Joint Development Committee 23 2.3 Alliance Managers 26 2.4 Joint Finance Committee 26 2.5 Joint Marketing Committee 28 3. RESEARCH PROGRAM 29 3.1 Objectives of the Research...Collaborative Development and License Agreement • November 3rd, 2006 • Immunogen Inc • Pharmaceutical preparations • New York
This COLLABORATIVE DEVELOPMENT AND LICENSE AGREEMENT (this “Agreement”) is entered into as of July 7, 2006 (the “Effective Date”), by and between ImmunoGen, Inc., a Massachusetts corporation with its principal place of business at 128 Sidney Street, Cambridge, Massachusetts, USA 02139 (“ImmunoGen”) and Biotest AG, a corporation organized under the laws of Germany having an address of Landsteinerstraße 5, D-63303 Dreieich, Germany (“Biotest”). Each of Biotest and ImmunoGen is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
